Form 425 HISTOGENICS CORP Filed by: HISTOGENICS CORP
Filed by Histogenics Corporation pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-6
under the Securities Exchange Act of 1934
Subject Company: Histogenics Corporation (SEC File No. 001-36751)
Commission File No. for the Related Registration Statement: 333-232147
URGENT ACTION NEEDED
Attention Histogenics Corporation Stockholder:
We have been trying to reach you. Histogenics
Corporation needs your vote today! Failure to
vote, or a vote against any proposal, puts the
merger with Ocugen, Inc. at risk.
You can call in your vote at: (877) 456-3402
PLEASE CALL TODAY.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
- Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
- Smart Share Global Limited Files Its Annual Report on Form 20-F
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!